CCLD
Get informed when a big investor buys or sells
+ FollowOvervalued by 88.9% based on the discounted cash flow analysis.
| Market cap | $857.28 Million |
|---|---|
| Enterprise Value | $864.42 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.1 |
| Beta | 1.6 |
| Outstanding Shares | 42,471,949 |
| P/E Ratio | 10.21 |
|---|---|
| PEG | -19.39 |
| Price to Sales | 1.18 |
| Price to Book Ratio | 2.35 |
| Enterprise Value to Revenue | 6.96 |
| Enterprise Value to EBIT | 102.24 |
| Enterprise Value to Net Income | 102 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.18 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.4064▲ 5.27% |
|---|---|
| Total Calls | 122,300▼ 6.78% |
| Total Puts | 172,000▼ 3.15% |
Holdings and activity of institutional investors.
| Ownership % | 3.19%▼ 21.70% |
|---|---|
| Total Invested | $44.03M▲ 42.97% |
| Investors Holding | 79▲ 6.00% |
No data
CareCloud, Inc. is a leading healthcare technology company with a comprehensive suite of proprietary, cloud-based solutions for growing healthcare organizations.
This is the primary committee for taxation, trade, and entitlement spending like Medicare and Medicaid. Changes in Medicare/Medicaid policy or reimbursement rates directly impact the financial health and technology investment capacity of CareCloud's healthcare provider customers.
This committee allocates discretionary federal spending. Its subcommittees determine the precise cash flow for federal healthcare programs and agencies, directly impacting the funding available to CareCloud's healthcare organization customers and potential federal contracts for health IT.
This committee directly regulates healthcare policy, standards, and the regulatory environment for healthcare providers, including those adopting technology like CareCloud's solutions. Decisions on health information technology, patient data, and interoperability fall under its direct purview.